Showing results (41-50 of 329) with videos related to
Sort By:
Pageof 33
BMC Nephrology|November 12, 2013
Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patientsAhsan Alam, Andrea Palumbo, Istvan Mucsi, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2020
The clinical utility of apoB versus LDL-C/non-HDL-CCiaran N Kohli-Lynch, George Thanassoulis, Andrew E Moran, et al.Circulation|October 20, 2004
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis StudyNaveed Sattar, Ken Williams, Allan D Sniderman, et al.Clinical Biochemistry|October 19, 2006
Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohortAndré J Tremblay, Allan D Sniderman, Claude Gagné, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Cardiovascular death in dialysis patients: lessons we can learn from AURORAAllan D Sniderman, Amirreza Solhpour, Ahsan Alam, et al.Clinical Science (London, England : 1979)|September 18, 2007
Non-HDL cholesterol and apoB in dyslipidaemiaAllan D Sniderman, Jean-Charles Hogue, Jean Bergeron, et al.Mayo Clinic Proceedings|October 2, 2013
The necessity for clinical reasoning in the era of evidence-based medicineAllan D Sniderman, Kevin J LaChapelle, Nikodem A Rachon, et al.Vascular Health and Risk Management|May 14, 2009
Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacinJennifer G RobinsonCurrent Atherosclerosis Reports|March 28, 2014
2013 ACC/AHA cholesterol guideline for reducing cardiovascular risk: what is so controversial?Jennifer G RobinsonThe American Journal of Cardiology|March 25, 2008
Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular riskJennifer G RobinsonPageof 33